Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079034/0/en/Alterity-Therapeutics-Prominently-Featured-at-the-International-MSA-Congress.html
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076109/0/en/Alterity-Therapeutics-Announces-Multiple-Oral-and-Poster-Presentations-to-be-Featured-at-the-International-MSA-Congress.html
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3073962/0/en/Alterity-Therapeutics-Granted-U-S-FDA-Fast-Track-Designation-for-ATH434-to-Treat-Multiple-System-Atrophy.html
28 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/28/3069098/0/en/Alterity-Therapeutics-Presents-ATH434-201-Phase-2-Clinical-Trial-Results-at-European-MSA-Symposium.html
10 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/10/3059151/0/en/Alterity-Therapeutics-Presents-Encouraging-New-Data-from-its-ATH434-Phase-2-Trial-in-Multiple-System-Atrophy-at-the-American-Academy-of-Neurology-Annual-Meeting.html
03 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/03/3055030/0/en/Alterity-Therapeutics-to-Deliver-an-Oral-Presentation-of-the-Positive-ATH434-Phase-2-Trial-Results-at-the-American-Academy-of-Neurology-Annual-Meeting.html
ABOUT THIS PAGE